Guest guest Posted May 26, 2011 Report Share Posted May 26, 2011 Potency, safety, and pharmacokinetics of the NS3/4A protease inhibitor BI201335 in patients with chronic HCV genotype–1 infection Journal of Hepatology Correlation between FIB4, liver stiffness and metabolic parameters in patients with HIV and hepatitis C virus co–infection Digestive and Liver Diseases Safety and efficacy of raltegravir in patients with HIV–1 and hepatitis B and/or C virus coinfection HIV Medicine Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.